{
  "id": 1024,
  "text": "It is undecided which of primary radical trachelectomy or NACT followed by FST is superior to the other in women with proven cervical cancer $> 2 \\ \\mathrm { c m }$ .Rate of possible fertility preserving surgery and obstetrical outcomes seems superior after NACT compared to upfront radical trachelectomy.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: It is undecided which of primary radical trachelectomy or NACT followed by FST is superior to the other in women with proven cervical cancer $> 2 \\ \\mathrm { c m }$ .Rate of possible fertility preserving surgery and obstetrical outcomes seems superior after NACT compared to upfront radical trachelectomy.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "针对直径超过2厘米的宫颈癌患者，在考虑保留生育能力的治疗方案时，与直接进行根治性宫颈切除术（Radical Trachelectomy, RT）相比，接受新辅助化疗（NACT）后再进行生育力保留手术可能具有一定的优势。主要体现在以下几个方面：\n\n1. **保留生育手术的可行性**：经过新辅助化疗后，肿瘤体积可能缩小到更适合生育力保留手术的范围，从而提高患者实施此类手术的可能性；相比之下，直接根治性宫颈切除术对较大病灶可能更具挑战性。\n\n2. **生殖和产科结果**：数据显示，新辅助化疗后进行生育力保留手术的患者，可能在生殖和产科结果方面表现更优（例如：较高的妊娠成功率和更理想的妊娠结局）。\n\n然而，具体选择哪种方案，仍需结合患者的具体病情、肿瘤分期、化疗耐受性、个人生育意愿及综合医疗团队的建议来决定。最终治疗方案应通过多学科协作来制定，以确保既能有效控制疾病，又最大限度地保留生育能力。",
  "query": "对于患有直径超过2厘米的宫颈癌女性，在考虑保留生育能力的治疗方案时，接受新辅助化疗后再进行生育力保留手术是否比直接进行根治性宫颈切除术更有优势？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于患有直径超过2厘米的宫颈癌女性，在考虑保留生育能力的治疗方案时，接受新辅助化疗后再进行生育力保留手术是否比直接进行根治性宫颈切除术更有优势？\n\n<reference text>: It is undecided which of primary radical trachelectomy or NACT followed by FST is superior to the other in women with proven cervical cancer $> 2 \\ \\mathrm { c m }$ .Rate of possible fertility preserving surgery and obstetrical outcomes seems superior after NACT compared to upfront radical trachelectomy.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "针对直径超过2厘米的宫颈癌患者，在考虑保留生育能力的治疗方案时，与直接进行根治性宫颈切除术（Radical Trachelectomy, RT）相比，接受新辅助化疗（NACT）后再进行生育力保留手术可能具有一定的优势。主要体现在以下几个方面：\n\n1. **保留生育手术的可行性**：经过新辅助化疗后，肿瘤体积可能缩小到更适合生育力保留手术的范围，从而提高患者实施此类手术的可能性；相比之下，直接根治性宫颈切除术对较大病灶可能更具挑战性。\n\n2. **生殖和产科结果**：数据显示，新辅助化疗后进行生育力保留手术的患者，可能在生殖和产科结果方面表现更优（例如：较高的妊娠成功率和更理想的妊娠结局）。\n\n然而，具体选择哪种方案，仍需结合患者的具体病情、肿瘤分期、化疗耐受性、个人生育意愿及综合医疗团队的建议来决定。最终治疗方案应通过多学科协作来制定，以确保既能有效控制疾病，又最大限度地保留生育能力。"
}